Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check3 days agoChange DetectedThe page shows a new revision tag, v3.7.0, replacing the previous v3.6.6, indicating an updated page version. This change appears to be a backend/documentation update rather than a modification to the study details or user-facing content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the study page.SummaryDifference0.0%

- Check24 days agoChange DetectedAn NIH grant/contract funding note (2016 U.S. NIH Grant/Contract) was added to the study's identifiers, providing funding attribution for the ALXN1210-PNH-301 trial.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page shows an updated revision number, moving from v3.6.4 to v3.6.5, indicating a small internal update to the page or site's framework.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing Revision: v3.6.3, indicating a new build/version of the page.SummaryDifference0.0%

- Check81 days agoChange DetectedThe study page now shows Revision: v3.6.3, replacing the previous v3.6.0. This indicates a newer page revision without changes to the study data or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.